Post Extraction Changes After Alveolar Socket Preservation Using Autogenous Dentin Graft (ADG) Combined With Either Albumin Platelet-rich Fibrin (ALB-PRF) or Standard Platelet-rich Fibrin (PRF). (Alb-PRF)

July 7, 2025 updated by: MUATH ATIF MOHAMEDAHMED HASSAN, Kafrelsheikh University

Comparison of Autogenous Dentin Graft With Albumin Platelet Rich Fibrin Versus Autogenous Dentin Graft With Platelet Rich Fibrin in Alveolar Socket Preservation: A Randomized Controlled Clinical Trial.

The study focuses on the impact of tooth loss on alveolar bone, which shrinks significantly within the first three months. To prevent this, strategies like alveolar ridge preservation are used.

Autogenous dentin, taken from the patient, supports healing and bone regrowth. Platelet-rich fibrin (PRF), made from the patient's blood, enhances healing and bone density by releasing growth factors.

A new technique combining L-PRF with albumin creates a stable healing membrane that provides a steady release of growth factors. Overall, these methods improve recovery after tooth extractions and prepare sites for future dental work.

Study Overview

Detailed Description

Study Design and Randomization:

  • Patients classified randomly using computer-generated randomization.
  • Performed by the supervisor.
  • Three main study groups established.
  • Decision for treatment group assignment based on randomized numbers in opaque sealed envelopes, picked by the supervisor.

Groups:

  1. Control Group:

    • 20 sockets with empty sockets to allow spontaneous healing post-extraction.
  2. Study Group 1:

    • 20 sockets receiving autogenous dentin graft and platelet-rich fibrin (PRF) block.
  3. Study Group 2:

    • 20 sockets receiving autogenous dentin graft and Albumin PRF (Alb-PRF) block.

Materials and Preparation

  1. Autogenous Dentin Graft:

    The tooth that has been removed will be thoroughly cleaned of any leftover periodontal ligaments, cementum, soft tissue connections, decay, or restorations using a high-speed fine finishing stone along with saline irrigation. Using sterile endodontic files, the pulp chamber will thoroughly be cleaned. Subsequently, the tooth will be ground using a Dentin grinding device to achieve a particle size between 300-1200 μm .The Autogenous Dentin Graft particles will be prepared by demineralizing tooth graft particles through immersion in 0.6N hydrochloric acid for 30 minutes. This will be followed by two rinses with saline and drying with sterile gauze.

  2. Platelet-Rich Fibrin (PRF):

    A sample of 10 ml intravenous blood will be collected from the median antecubital vein of the patient. This blood will be placed in 10 ml glass tubes without any additives and will be immediately centrifuged at 3000 RPM for 10 minutes at room temperature. The tube will be separated into three parts, namely, a packed red blood cell at the bottom, acellular plasma at the top, and the PRF clot in between. The PRF clot will be extracted from the tube with the help of sterile tweezers and a surgical blade and then placed in the PRF box to obtain a membrane.

  3. Albumin Platelet Rich Fibrin (Alb-PRF):

Nine milliliters of blood in plastic tubes will be centrifuged at 700 g for 8 minutes using an Eppendorf centrifugate. The upper layer (platelet-poor plasma layer) was collected in 2-mL syringes and heated at 75°C for 10 minutes to create denatured albumin (albumin gel). Following heating, the albumin gel was allowed to cool to room temperature for 10 minutes. Then, liquid PRF including remaining cells and growth factor found within the buffy coat layer was thereafter mixed back together with the cooled albumin gel to form Alb-PRF using a female-female luer lock connector. This combination allowed that both the lower-resorption properties of the albumin gel along with the higher cell content and growth factor content of the liquid PRF layer to be remixed. The injectable Alb-PRF gels will then be transferred into culture plate forming a gelated ALB-PRF membrane.

Preoperative Evaluation:

  • Clinical examination to confirm eligibility.
  • Full mouth charting for periodontal evaluation.
  • Patient education on plaque control and oral hygiene.
  • Supra & subgingival debridement performed.

Clinical Procedure:

  • Pre-extraction rinse with 0.12% chlorhexidine.
  • Local anesthesia using 2% mepivacaine HCL with levonordefrin.
  • Tooth extraction via minimally traumatic flapless technique.
  • Evaluation of extraction socket integrity.

Post-Extraction Treatment

  • Control Group: Left the socket empty for healing.
  • For the Autogenous Dentin Graft with Platelet Rich Fibrin Block group:

Use surgical curved scissors to cut the two L-PRF membranes into very small pieces, mix chopped membranes and dentin substitute in Ti-dish (2 membranes / 0.5g dentin graft), Add 1 cc of liquid fibrinogen to the homogeneous mixture and gently stir for 5 to 10 seconds while shaping it into the desired form, Fibrinogen will clot into fibrin within a few minutes and trap the biomaterial to form a L-PRF block. the graft will be placed into the socket and will be Covered with a PRF membrane and secured with a single crisscross 5-0 polypropylene suture.

- For the Autogenous Dentin Graft with Albumin Platelet Rich Fibrin group: Mixing the autogenous dentin particles with ALB-PRF in a 1:1 ratio to create a cohesive graft material (dentin block). The graft material is now fully prepared for use. the graft will be placed into the socket and will be Covered with a gelated ALB-PRF membrane. sutured by a single crisscross 5-0 polypropylene suture.

Postsurgical Care Instructions:

  1. Avoid Trauma: Do not disturb the surgical site or sutures.
  2. Diet: Avoid hot food and refrain from rinsing your mouth.
  3. Oral Hygiene: Do not brush the surgical area for 2 weeks; gentle brushing can resume afterward.
  4. Medications:

    • Take Amoxicillin 500mg three times daily for 10 days or Doxycycline 100mg twice daily if allergic to penicillin.
    • Use Ibuprofen 600mg for severe pain as needed.
  5. Mouthwash: Use a 0.12% chlorhexidine mouthwash for gentle rinsing, twice daily for 2 weeks.
  6. Postoperative Issues: Contact your physician immediately if you experience abnormal bleeding.
  7. Suture Removal: Sutures will be removed 2 weeks after surgery.
  8. Follow-up: Schedule a follow-up appointment 6 months after the procedure.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Kafrelsheikh
      • Kafr Ash Shaykh, Kafrelsheikh, Egypt, 6860404
        • Recruiting
        • Kaferelsheikh University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Medically free patients.
  • Adult patients above 18 Years to 60 Years.
  • Non-restorable tooth indicated for extraction.
  • Posterior mandibular teeth.
  • Inactive infection related to the tooth.
  • Cooperative patients.

Exclusion Criteria:

  • Presence of any systemic disease that could influence the outcome of the therapy.
  • Presence of any risk factor (smoker, pregnant and lactating patients).
  • Patients with bone diseases.
  • Patients with poor oral hygiene.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: empty socket
Patients will be left socket empty without any graft materials for spontaneous healing process after tooth extraction
Active Comparator: Autogenous Dentin Graft with Platelet Rich Fibrin
Patients will be inserting autogenous dentin graft and platelet rich fibrin in the socket after extraction.
Experimental: Autogenous Dentin Graft with Albumin Platelet Rich Fibrin
Patients will be inserting autogenous dentin graft and Albumin Platelet Rich Fibrin in the socket after extraction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar ridge width (buccolingual).
Time Frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the buccolingual width by measuring the distance between buccal and lingual bone walls.
at baseline immediately after extraction and after six months
Alveolar ridge height (apicocronal)
Time Frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the apicocronal height by measuring the ridge height from the top of the alveolar ridge to the upper border of the alveolar canal.
at baseline immediately after extraction and after six months
Bone density
Time Frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) The measurement helps in assessing the quality of bone directly through Hounsfield units (HU) (between D1 and D5; D1: > 1250 HU, D2: 850 to 1250 HU, D3: 350 to 850 HU, D4: 150 to 350 HU, D5: < 150 HU).
at baseline immediately after extraction and after six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain scores
Time Frame: at 24 hours, 3 days, 7 days and 14 days postoperative
The patients will report their pain score directly through VAS score (between 0 and 10; 0: no pain, 1: minimal pain, 5: moderate pain, and 10: severe pain).
at 24 hours, 3 days, 7 days and 14 days postoperative
Patient satisfaction
Time Frame: at 24 hours, 3 days, 7 days,14 days postoperative and after six months
Will use Surveys/Questionnaires to assess patient satisfaction regarding treatment outcomes and experiences. The patients will report their satisfaction score directly through satisfaction score (between 0 and 4; 0: Very satisfied, 1: Satisfied, 2: Neither satisfied nor dissatisfied, 3: Dissatisfied, 4: Very dissatisfied).
at 24 hours, 3 days, 7 days,14 days postoperative and after six months
Keratinized tissue width
Time Frame: at baseline before extraction and after six months

Will be assessed through probing techniques before and 6 months after surgical intervention.

The measurements will be taken at the vertical distance from a line connecting the two neighboring teeth at the CEJs to the free gingival margin (FGM) using a UNC 15 probe (Nordent Manufacturing Inc., IL, USA).

at baseline before extraction and after six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Enas Ahmed Elgendy, PhD, Kaferelsheikh University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

December 26, 2024

First Submitted That Met QC Criteria

December 26, 2024

First Posted (Actual)

January 3, 2025

Study Record Updates

Last Update Posted (Actual)

July 10, 2025

Last Update Submitted That Met QC Criteria

July 7, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • KFSIRB200-471

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Socket Preservation

Clinical Trials on empty socket

Subscribe